Jimi Kim

Prof. Dr. Jimi Kim

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJimi Kim
Jimi Kim
JLJeonghee Lee
Jeonghee Lee
JOJae Hwan Oh
Jae Hwan Oh
HCHee Jin Chang
Hee Jin Chang
DSDae Kyung Sohn
Dae Kyung Sohn
JKJeongseon Kim
Jeongseon Kim
It is unclear whether dietary lutein/zeaxanthin intake in colorectal cancer is associated with microRNA processing involved in DICER1 cleavage for messenger RNA translation. We investigated whether dietary lutein/zeaxanthin intake affects colorectal cancer risk in patients with a DICER1 rs3742330 polymorphism. In this hospital-based case-control study, we recruited 923 colorectal cancer patients and 1,846 controls based on eligibility criteria, a semiquantitative food frequency questionnaire and the DICER1 rs3742330 genotype. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by unconditional logistic regression adjusted for confounders. The highest quartile of lutein/zeaxanthin consumption was inversely associated with a reduced colorectal cancer risk (OR, 95% CI = 0.25, 0.18–0.36). Carrying G allele (AG + GG) showed a significantly reduced colorectal cancer incidence compared with that of AA carriers (OR, 95% CI = 0.71, 0.55–0.91). Those carrying the G allele (AG + GG) along with high lutein/zeaxanthin consumption were markedly associated with a decreased colorectal cancer risk (OR, 95% CI = 0.32, 0.22–0.46, P for interaction = 0.018), particularly for rectal cancer (OR, 95% CI = 0.24, 0.15–0.39, P for interaction = 0.004), compared with that of AA carriers with low lutein/zeaxanthin intakes. In conclusion, colorectal cancer risk was related to an interactive effect between dietary lutein/zeaxanthin intake and the DICER1 rs3742330 polymorphism.

12 July 2019 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
JKJimi Kim
Jimi Kim
JLJeonghee Lee
Jeonghee Lee
JOJae Hwan Oh
Jae Hwan Oh
HCHee Jin Chang
Hee Jin Chang
DSDae Kyung Sohn
Dae Kyung Sohn
JKJeongseon Kim
Jeongseon Kim

28 November 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
JKJimi Kim
Jimi Kim
JLJeonghee Lee
Jeonghee Lee
JOJae Hwan Oh
Jae Hwan Oh
HCHee Jin Chang
Hee Jin Chang
DSDae Kyung Sohn
Dae Kyung Sohn
JKJeongseon Kim
Jeongseon Kim
Chronic inflammation is one of the causes of colorectal cancer (CRC), and circulating levels of inflammatory biomarkers have been linked to tumor promotion and progression. We aimed to evaluate the interleukin-6 (IL-6) level in CRC patients and determine whether a diet rich in antioxidants was associated with CRC. This study included 654 cases and 1312 controls matched for age and sex. We measured the plasma IL-6 concentration and estimated dietary antioxidant capacity based on oxygen radical absorbance capacity (ORAC) combined with a 106-item semiquantitative food frequency questionnaire. The IL-6 concentration was significantly increased in individuals with CRC (OR Q4 vs. Q1, 95% CI = 6.23, 4.10–9.45, p < 0.001). High dietary ORAC showed an inverse association with CRC (total ORAC OR Q4 vs. Q1, 95% CI = 0.26, 0.16–0.40, p < 0.001; total phenolics = 0.32, 0.21–0.50, p < 0.001). We found that low dietary ORAC was associated with a significant increase in CRC in the group with elevated IL-6 levels (total ORAC OR Q4 vs. Q1, 95% CI = 4.34, 3.12–6.02, p < 0.001; total phenolics = 4.61, 3.33–6.39, p < 0.001). This study suggested an inverse association between dietary antioxidant capacity and IL-6 level among patients with CRC.

1 September 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
JKJimi Kim
Jimi Kim
JLJeonghee Lee
Jeonghee Lee
JOJae Hwan Oh
Jae Hwan Oh
HCHee Jin Chang
Hee Jin Chang
DSDae Kyung Sohn
Dae Kyung Sohn
JKJeongseon Kim
Jeongseon Kim

17 October 2022 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
JKJimi Kim
Jimi Kim
JLJeonghee Lee
Jeonghee Lee
ICIl Ju Choi
Il Ju Choi
YKYoung-Il Kim
Young-Il Kim
JKJeongseon Kim
Jeongseon Kim
OBJECTIVES: Gastric carcinogenesis is linked to oxidative stress from both exogenous and endogenous exposures. This study aimed to determine the association between the risk of gastric cancer and the oxidative balance score (OBS), which comprises antioxidant and pro-oxidant factors, including diet and lifestyle.METHODS: For this hospital-based case-control study, 808 controls and 404 patients with gastric cancer who had clinical records indicating Helicobacter pylori infection and the histological subtype of cancer were recruited. The OBS was determined based on diet and lifestyle factors obtained from a 106-item semiquantitative food frequency questionnaire and a constructed questionnaire. Logistic regression analysis was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).RESULTS: A higher OBS was associated with a reduced gastric cancer risk (OR, 0.49; 95% CI T3 vs. T1, 0.33 to 0.71; p for trend <0.001). In a subgroup analysis, antioxidant factors showed inverse associations with gastric cancer risk (OR, 0.53; 95% CI T3 vs. T1, 0.35 to 0.79; p for trend=0.003). A stronger association with antioxidant factors was observed in patients with intestinal gastric cancer (OR, 0.34; 95% CI T3 vs. T1, 0.19 to 0.62; p for trend<0.001) and those with H. pylori infection (OR, 0.57; 95% CI T3 vs. T1, 0.37 to 0.88; p for trend=0.014).CONCLUSIONS: A predominance of antioxidant factors compared to pro-oxidant factors from diet and lifestyle reduced the risk of gastric cancer. The combined effect of oxidative stress, which involves an altered balance between antioxidants and pro-oxidants, is important for modulating the risk of gastric cancer.

28 July 2025 in Diseases
Verified
Journal Article
Open access
PDF file
JKJimi Kim
Jimi Kim
Background: Metabolic syndrome (MetS) is a multifactorial condition involving central obesity, dyslipidemia, hypertension, and impaired glucose metabolism, significantly increasing the risk of type 2 diabetes and cardiovascular disease. Objectives: Given the clinical heterogeneity of MetS, this study aimed to identify distinct metabolic phenotypes, referred to as metabotypes, using validated biomarkers and to examine their association with MetS. Materials and Methods: A total of 1245 Korean adults aged 19–79 years were selected from the 2016–2023 Korea National Health and Nutrition Examination Survey. Metabotype risk clusters were derived using k-means clustering based on five biomarkers: body mass index (BMI), uric acid, fasting blood glucose (FBG), high-density lipoprotein cholesterol (HDLc), and non-HDL cholesterol (non-HDLc). Multivariable logistic regression was used to assess associations with MetS. Results: Three distinct metabotype risk clusters (low, intermediate, and high risk) were identified. The high-risk cluster exhibited significantly worse metabolic profiles, including elevated BMI, FBG, HbA1c, triglyceride, and reduced HDLc. The prevalence of MetS increased progressively across metabotype risk clusters (OR: 5.46, 95% CI: 2.89–10.30, p < 0.001). In sex-stratified analyses, the high-risk cluster was strongly associated with MetS in both men (OR: 9.22, 95% CI: 3.49–24.36, p < 0.001) and women (OR: 3.70, 95% CI: 1.56–8.75, p = 0.003), with notable sex-specific differences in lipid profiles, particularly in HDLc. Conclusion: These findings support the utility of metabotyping using routine biomarkers as a tool for early identification of high-risk individuals and the development of personalized prevention strategies in clinical and public health settings.